Nuvation Bio Inc.

This study tests a new drug called NUV-1511 in adults with advanced solid tumors that have not responded to other treatments. The goal is to find safe doses and see if the drug can shrink tumors. The study includes people with certain breast, prostate, pancreatic, and ovarian can…

This study tests a new drug called AB-106 in people with advanced non-small cell lung cancer that has a specific genetic change (ROS1 fusion). The goal is to see if the drug can shrink tumors and to check for side effects. About 173 adults will receive the drug and be monitored f…

This program gives adults with advanced or spreading ROS1-positive non-small cell lung cancer access to taletrectinib when they cannot use approved treatments or join ongoing studies. It is for patients who, in their doctor's opinion, might benefit from the drug. The goal is to p…

This study tests a drug called taletrectinib in people with advanced lung cancer that has a specific genetic change (ROS1 positive). The goal is to see if the drug can shrink tumors and how safe it is. About 217 participants will receive the drug, and researchers will measure res…